100 related articles for article (PubMed ID: 7692621)
1. Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
Wakugami T; Islam MR; Higa S; Murakami K; Mimura G
Tohoku J Exp Med; 1993 Jan; 169(1):21-9. PubMed ID: 7692621
[TBL] [Abstract][Full Text] [Related]
2. Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506.
Kai N; Motojima K; Tsunoda T; Kanematsu T
Transplantation; 1993 Apr; 55(4):936-40. PubMed ID: 7682740
[TBL] [Abstract][Full Text] [Related]
3. Synergy between tetrandrine and FK506 in prevention of diabetes in BB rats.
Lieberman I; Heil BV; Seow WK; Thong YH
Life Sci; 1993; 53(26):PL453-8. PubMed ID: 7504774
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
[TBL] [Abstract][Full Text] [Related]
5. A dithiocarbamate analogue decreases intraislet cell infiltration and the incidence of diabetes mellitus in the genetic diabetes-prone BB rat.
Pieper GM; Henderson JD; Roza AM; Lai CS
Pancreas; 2004 Jan; 28(1):e16-25. PubMed ID: 14707744
[TBL] [Abstract][Full Text] [Related]
6. Immunological and metabolic concomitants of cyclosporin prevention of diabetes in BB rats.
Yale JF; Grose M; Seemayer TA; Marliss EB
Diabetes; 1987 Jun; 36(6):749-57. PubMed ID: 3569673
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin on pancreatic events and development of diabetes in BB/Edinburgh rats.
Bone AJ; Walker R; Varey AM; Cooke A; Baird JD
Diabetes; 1990 Apr; 39(4):508-14. PubMed ID: 2180761
[TBL] [Abstract][Full Text] [Related]
8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
9. The effect of FK506 and cyclosporin A on antigen-induced arthritis.
Blackham A; Griffiths RJ
Clin Exp Immunol; 1991 Nov; 86(2):224-8. PubMed ID: 1718639
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for insulin-dependent diabetes mellitus in the "BB" rat.
Thliveris JA; Begleiter A; Manchur D; Johnston JB
Life Sci; 1997; 61(3):283-91. PubMed ID: 9217288
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
[TBL] [Abstract][Full Text] [Related]
12. Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats.
Lieberman I; Lentz DP; Trucco GA; Seow WK; Thong YH
Diabetes; 1992 May; 41(5):616-9. PubMed ID: 1568531
[TBL] [Abstract][Full Text] [Related]
13. Effects of PGE1 on the development of diabetes and surface markers of lymphocytes in BB/W/Tky rats.
Suzuki M; Negishi K; Itabashi A; Katayama S; Ishii J; Komeda K; Kawazu S
Diabetes Res; 1991 Oct; 18(2):95-9. PubMed ID: 1841818
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression in autoimmune disease: the double-edged sword.
Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide inhibits the development of diabetes in the diabetes-prone BB rat.
Sobel DO; Ahvazi B; Jun HS; Chung YH; Yoon JW
Diabetologia; 2000 Aug; 43(8):986-94. PubMed ID: 10990075
[TBL] [Abstract][Full Text] [Related]
16. The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
Mysliwiec J; Azzadin A; Chabielska E; Takada A; Mysliwiec M; Buczko W
Thromb Res; 1996 Jul; 83(2):175-81. PubMed ID: 8837316
[TBL] [Abstract][Full Text] [Related]
17. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
[TBL] [Abstract][Full Text] [Related]
19. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
Dusting GJ; Akita K; Hickey H; Smith M; Gurevich V
Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
